| Literature DB >> 32457456 |
Qurat Ul Ain Farooq1, Zeeshan Shaukat2, Tong Zhou1, Sara Aiman1, Weikang Gong1, Chunhua Li3.
Abstract
Human papilloma virus (HPV) is a serious threat to human life globally with over 100 genotypes including cancer causing high risk HPVs. Study on protein interaction maps of pathogens with their host is a recent trend in 'omics' era and has been practiced by researchers to find novel drug targets. In current study, we construct an integrated protein interaction map of HPV with its host human in Cytoscape and analyze it further by using various bioinformatics tools. We found out 2988 interactions between 12 HPV and 2061 human proteins among which we identified MYLK, CDK7, CDK1, CDK2, JAK1 and 6 other human proteins associated with multiple viral oncoproteins. The functional enrichment analysis of these top-notch key genes is performed using KEGG pathway and Gene Ontology analysis, which reveals that the gene set is enriched in cell cycle a crucial cellular process, and the second most important pathway in which the gene set is involved is viral carcinogenesis. Among the viral proteins, E7 has the highest number of associations in the network followed by E6, E2 and E5. We found out a group of genes which is not targeted by the existing drugs available for HPV infections. It can be concluded that the molecules found in this study could be potential targets and could be used by scientists in their drug design studies.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32457456 PMCID: PMC7251128 DOI: 10.1038/s41598-020-65837-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1HPV-Human protein interaction network constructed in Cytoscape. The network comprises of 2073 nodes (proteins) with 2988 edges (interactions) between them. HPV proteins form highly connected hubs. The network is mapped according to node size. The lesser the number of interactions, the smaller the size of the node. HPV proteins E7 and E6 are of largest node size, indicating their substantial numbers of interactions. Viral proteins are represented in a uniform yellow color while human proteins in different colors. Host proteins with high numbers of interactions have larger node size (colored in bright red) compared to the proteins with lower numbers of associations (light purple).
Statistics of the PPI network constructed between HPV-Human.
| Attributes | Values |
|---|---|
| Num. of Nodes | 2073 |
| Num. of Edges | 2988 |
| Avg. Degree | 2.883 |
| High score interacting viral proteins | E7, E6, E2, E5 |
| Clustering Coefficient | 0.001 |
| Network Density | 0.001 |
| Shortest Paths | 4262192 (99%) |
Figure 2Numbers of interactions HPV proteins have in the overall network.
Figure 3(a) Betweenness centrality and (b) clustering coefficient values of HPV proteins in the interaction network with the x-axis representing their degrees.
Pathway enrichment analysis of the top 25 host genes ranked by CytoHubba on the basis of MCC.
| Gene set | Description | Size | P value | FDR value |
|---|---|---|---|---|
| hsa04270 | Vascular smooth muscle contraction | 121 | 5.4 × 10−6 | 1.8 × 10−3 |
| hsa04611 | Platelet activation | 123 | 1.4 × 10−4 | 2.3 × 10−2 |
| hsa05203 | Viral carcinogenesis | 201 | 9.2 × 10−4 | 5.9 × 10−2 |
| hsa04540 | Gap junction | 88 | 9.5 × 10−4 | 5.9 × 10−2 |
| hsa04666 | Fc gamma R-mediated phagocytosis | 91 | 1.0 × 10−3 | 5.9 × 10−2 |
| sa04658 | Th1 and Th2 cell differentiation | 92 | 1.1 × 10−3 | 5.9 × 10−2 |
| hsa04914 | Progesterone-mediated oocyte maturation | 99 | 1.3 × 10−3 | 6.2 × 10−2 |
| hsa04659 | Th17 cell differentiation | 107 | 1.7 × 10−3 | 6.8 × 10−2 |
| hsa04110 | Cell cycle | 124 | 2.6 × 10−3 | 8.3 × 10−2 |
| hsa04114 | Oocyte meiosis | 124 | 2.5 × 10−3 | 8.3 × 10−2 |
Figure 4KEGG pathway analysis of top 11 highly HPV-associated human genes. The genes are a part of one of the chief cellular pathways i.e. cell cycle, viral carcinogenesis and p53 signalling pathway. The genes are also involved in several other pathways including progesterone-mediated oocyte maturation, oocyte meiosis, measles and HCV but the intensity of their involvement in these pathways is lesser. The length and color of the bar represent the intensity of the genes enriched in the pathway/process. The longer the bar and lighter the color, the more enriched the gene set in the specific pathway.
Figure 5Gene Ontology of top 11 highly HPV-associated human genes. (a) The gene set is an important part of the DNA damage response which involves a cascade of processes activated by the p53 protein (GO:0030330), and also a part of cell cycle checkpoints including G1/S transition checkpoint (GO:0044819), G1 DNA damage checkpoint (GO:0044783), and a part of various other transition phases of cell cycle. (b) GO cellular component analysis reveals that the gene set is a major component of cyclin-dependent kinase activating kinase complexes responsible for cell cycle progression regulation (GO:0019907). The gene set is also a part of holo TFIIH complex (GO:0005675), a transcription factor essential for initiation of promoters. (c) GO molecular function analysis of the gene set shows that it is responsible for catalysis of a group of reactions and requires a CDK activity. The gene set is clearly involved in the regulation of cell cycle and the molecular functions they exhibit are cyclin-dependent protein serine/threonine kinase activity (GO:0004693), cyclin-dependent protein kinase activity (GO:0097472), histone kinase activity (GO:0035173) and several others as mentioned in the figure.
Figure 6Clusters formed by CytoCluster using a hierarchical clustering algorithm. Viral proteins are represented as yellow nodes while human proteins are denoted in blue.
List of studies with accessible protein-protein interaction data of HPV-host.
| No. | Paper | Num. of Interactions | Method of PPI detection | Ref |
|---|---|---|---|---|
| 1 | Gulati | 1 | Mass spectrometry | [ |
| 2 | Drews | 1 | Co-transfection | [ |
| 3 | Yang | 1906 | HPIDB | [ |
| 4 | Eckhardt | 137 | Mass Spectrometry | [ |
| 5 | DeSmet | 4 | Co-immunoprecipitation, Mass Spectrometry | [ |
| 6 | Sankovski | 1 | Co-immunoprecipitation, Mass Spectrometry | [ |
| 7 | Poirson | 47 | Co-immunoprecipitation, GPCA | [ |
| 8 | Spriggs | 3 | Chromatin Immunoprecipitation (ChIP) | [ |
| 9 | Dong | 877 | IntAct, APID, VirHostNet | [ |
| 10 | Tang | 1 | Yeast 2 Hybrid, Co-immunoprecipitation | [ |
| 11 | Jang | 253 | Tandem affinity purification, Mass spectrometry | [ |
| 12 | Kanginakudru | 1 | Chromatin immunoprecipitation (ChIP) | [ |
| 13 | Muller | 57 | VirHostNet, VirusMint, PubMed | [ |
| 14 | Woodham | 1 | Co-immunoprecipitation, Electron Paramagnetic Resonance | [ |
| 15 | Muller | 53 | Yeast 2 Hybrid | [ |
| 16 | Yaginuma | 1 | Yeast 2 Hybrid, Co-immunoprecipitation | [ |
| 17 | Xu | 1 | Chromatin immunoprecipitation (ChIP) | [ |
| 18 | Fertey | 1 | Yeast 2 Hybrid, Co-immunoprecipitation | [ |
| 19 | Côté-Martin | 1 | Tandem affinity purification, Mass spectrometry | [ |
| 20 | Wu | 2 | GST pull down assay, Co-transfection | [ |
| 21 | Zhang | 2 | Immunoprecipitation, Transient transfection | [ |
| 22 | Bernat | 1 | Mammalian two-hybrid assay, Chloramphenicol acetyltransferase (CAT) reporter assay, GST pull-down assay and coimmunoprecipitation | [ |
| 23 | Finnen | 1 | Co-immunoprecipitation | [ |
| 24 | Yang | 1 | Immunoprecipitation,Indirect Immunofluorescence | [ |
| 25 | Mantovani | 1 | GST assay | [ |
| 26 | Massimi | 1 | Binding assays, Transient DNA replication assay, co-immunoprecipitation. | [ |
| 27 | Thomas | 1 | Co-transfection | [ |
| 28 | Patel | 2 | Co-immunoprecipitation, GST pull-down assay | [ |
| 29 | Daniels | 2 | Immunoprecipitation, Indirect immunofluorescence analysis | [ |
| 30 | Swindle | 1 | Co-immunoprecipitation | [ |
| 31 | Jones et al. (1996) | 1 | Co-immunoprecipitation | [ |
| 32 | Antinore et al. (1996) | 4 | Immunoprecipitation, Yeast two-hybrid system | [ |